In research published in the Jan. 17 issue of The Journal of Cell Biology, a team led by Susana Gonzalo, Ph.D., assistant professor of…

Since 1992 the number of deaths linked to breast cancer in Spain has decreased among young and middle aged patients but not among the elderly. Spanish researchers…

Breast cancer is the second leading cause of cancer deaths among women in the United States. Many of these deaths occur…

Spin and bias exist in a high proportion of published studies of the outcomes and adverse side-effects of phase III clinical trials of breast cancer treatments, according…

For older women, cheaper methods of detecting breast cancer may be as good as more expensive ones, according to the latest research.

Medicare spending on breast cancer screenings like…

Medicare spends almost as much money screening for breast cancer as it does treating it, according to a new study published in JAMA Internal Medicine.

Breast cancer screenings cost Medicare $1.08…

New research published in the January issue of The Journal of Nuclear Medicine shows that 18F-fludeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT)…

Australian scientists have shown in the laboratory how a ‘transcription factor’ causes breast cancer cells to develop an aggressive subtype that lacks sensitivity to estrogen and does not…

The discovery that a protein which triggers milk production in women may also be responsible for making breast cancers aggressive could open up new opportunities for treatment of the…

Over the past couple of years research into miRNAs has become increasingly diversified and attracted a great number of research articles across genetics and medicine. This should hardly come as…

The DNA mutations that accumulate over time as women age are not the sole contributor to the higher frequency of breast cancer in…

European health regulators recommended Roche’s breast cancer drug Perjeta for approval on Friday, cementing the company’s hopes that the drug will become the standard of care for an…

Women who have higher levels of nutrients commonly found in vegetables may have a lower risk of developing breast cancer, say researchers at Brigham & Women’s…

A randomized trial found bevacizumab (Avastin) failed to improve outcomes in combination with chemotherapy in early triple-negative breast cancer, adding to the string of failures for the drug.

Invasive…

Vitamin D levels may be part of the reason some women saw a benefit from adding a bone drug to standard breast cancer chemotherapy regimens, a researcher said.

Postmenopausal women…

One of the most frustrating truths about cancer is that even when a treatment works, it often doesn’t work for long because cancer cells find ways to…

Current screening tests may miss as many as 1 in 50 women with breast cancer who would benefit from treatment with highly effective breast cancer drugs.

At issue is…

While pink is usually the color most associated with breast cancer advocacy, women may want to think red and orange if they’re looking to lower…

More patients can benefit from highly effective breast cancer drugs that are already available, according to DNA sequencing studies by researchers at Washington University School of Medicine in St.…

Inflammatory breast cancer (IBC) is a very rare and aggressive disease that progresses rapidly and is associated with a very low survival rate. To understand how this…

Swiss pharma group Roche’s drug Perjeta significantly extended the lives of women with an aggressive and incurable form of breast cancer compared to a placebo, according to new data from…

A new review of existing evidence suggests that using magnetic resonance imaging to “stage” a woman’s breast cancer before surgery might do more harm than good.

MRI produces a…

Genomic sequencing has revealed therapeutic drug targets for difficult-to-treat, metastatic triple-negative breast cancer (TNBC), according to an unprecedented study by the Translational Genomic Research Institute (TGen)…

African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive…

Most patients whose breast cancer has spread to their lymph nodes have most of the lymph nodes in their armpit area removed after chemotherapy to…